Scientist and consultant with a background in oncology and immunology, working in basic and translational research. Stephane Terry hold a PhD from the University of Paris-Sud (Paris-Saclay), with early research focused on tumor progression, therapy resistance, and biomarker discovery through close collaboration with clinical and research teams in France and the U.S. His interests have progressively evolved toward tumor immunology, particularly mechanisms of immune evasion involving NK and T cells, and advancing innovative therapeutic strategies in oncology and beyond, more recently exploring how immune responses influence the efficacy of gene therapy.